发明授权
US07256253B2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
失效
通过与血液成分缀合,保护内源性治疗肽免受肽酶活性的影响
- 专利标题: Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
- 专利标题(中): 通过与血液成分缀合,保护内源性治疗肽免受肽酶活性的影响
-
申请号: US11066697申请日: 2005-02-25
-
公开(公告)号: US07256253B2公开(公告)日: 2007-08-14
- 发明人: Dominique P. Bridon , Alan M. Ezrin , Peter G. Milner , Darren L. Holmes , Karen Thibaudeau
- 申请人: Dominique P. Bridon , Alan M. Ezrin , Peter G. Milner , Darren L. Holmes , Karen Thibaudeau
- 申请人地址: CA Montreal
- 专利权人: ConjuChem Biotechnologies Inc.
- 当前专利权人: ConjuChem Biotechnologies Inc.
- 当前专利权人地址: CA Montreal
- 代理机构: Jones Day
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; C07K14/00
摘要:
A secretin or secretin derivative protected against peptidase activity. The secretin or derivative comprises a peptidic sequence and a reactive group selected from the group consisting of succinimidyl and maleimido groups capable of reacting with an amino group, hydroxyl group or thiol group on a blood component to form a stable covalent bond. The reactive group is attached at a position along the peptidic sequence that provides, when conjugated to a blood component, a higher stability against peptidase degradation than the unconjugated secretin or derivative, and therefore an increased maintenance of the therapeutic activity compared to the unconjugated secretin or derivative. Such a compound is thus effective to provide a source of secretin having a high stability against peptidases. A method for synthesizing such a compound is also described.
公开/授权文献
信息查询
IPC分类: